Global Health Leaders Gather in Nairobi for Historic ISSAD Conference on Group B Streptococcus
By Bruno Aero Family Media Health correspondance Dr Hellen Barsosio Head of Maternal & Newborn Health Interventions KEMRI. Nairobi, Kenya | February 23-25, 2026 - The 2026 International Symposium on Streptococcus agalactiae Disease (ISSAD) opens today in Nairobi, Kenya, marking a historic milestone as the first time this premier global conference has been hosted in East Africa. From February 23-25, world-renowned scientists, public health officials, and vaccine developers will convene in Kenya's capital to accelerate progress toward preventing Group B Streptococcus (GBS), a leading cause of neonatal sepsis, postpartum infections, and infant mortality worldwide. Group B Streptococcus remains a major global health threat, with an estimated 18-20 million or 1 in 5 pregnant women globally carrying GBS each year. GBS is responsible for approximately 400,000 cases of invasive disease annually in infants, including sepsis and meningitis, and is linked to...
